Management and Outcome of Permanent Pacemaker and Implantable Cardioverter-Defibrillator Infections
Muhammad R. Sohail, MD*,*,1,
Daniel Z. Uslan, MD*,3,
Akbar H. Khan, MD
,2,
Paul A. Friedman, MD
,
David L. Hayes, MD
,
Walter R. Wilson, MD*,
James M. Steckelberg, MD*,
Sarah Stoner, MS
and
Larry M. Baddour, MD*
* Division of Infectious Diseases, Mayo Clinic College of Medicine, Rochester, Minnesota.
Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, Minnesota.
Department of Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota.
Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota.

View larger version (34K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 2 Timing of Reimplantation of New Cardiac Device and Duration of Postexplantation Antibiotic Treatment
Blue bars = time from explant to reimplant; red bars = post-explant antibiotic duration. CoNS = coagulase-negative staphylococci; other abbreviations as in Figure 1.
|
|

View larger version (18K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 3 Mayo Clinic Algorithm of Cardiac Device Infection Management
(A) Approach to management of adults with PPM/ICD infection (also see Table 4). This algorithm applies only to the patients with complete device explantation. *Duration of antibiotics should be counted from the day of device explantation. (B) Guidelines for reimplantation of new device in patients with PPM/ICD infection (see also Table 4). AHA = American Heart Association; TEE = transesophageal echocardiography; other abbreviations as in Figure 1.
|
|
Copyright © 2007 by the American College of Cardiology Foundation.